Long-Term Evolution of Malnutrition and Loss of Muscle Strength after COVID-19: A Major and Neglected Component of Long COVID-19.
Adult
Aged
COVID-19
/ complications
Female
Functional Status
Hospitalization
Humans
Length of Stay
Male
Malnutrition
/ diagnosis
Middle Aged
Muscle Strength
Muscle Weakness
/ diagnosis
Muscle, Skeletal
/ physiopathology
Nutritional Status
Obesity
/ complications
Prognosis
Prospective Studies
Risk Assessment
Risk Factors
Time Factors
Post-Acute COVID-19 Syndrome
cohort study
intensive care unit
long COVID-19
malnutrition
muscle strength
obesity
performance status
self-evaluation
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
06 Nov 2021
06 Nov 2021
Historique:
received:
01
09
2021
revised:
29
10
2021
accepted:
03
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Post-acute consequences of COVID-19, also termed long COVID, include signs and symptoms persisting for more than 12 weeks with prolonged multisystem involvement; most often, however, malnutrition is ignored. The objective was to analyze persistent symptoms, nutritional status, the evolution of muscle strength and performance status (PS) at 6 months post-discharge in a cohort of COVID-19 survivors. Of 549 consecutive patients hospitalized for COVID-19 between 1 March and 29 April 2020, 23.7% died and 288 patients were at home at D30 post-discharge. At this date, 136 of them (47.2%) presented persistent malnutrition, a significant decrease in muscle strength or a PS ≥ 2. These patients received dietary counseling, nutritional supplementation, adapted physical activity guidance or physiotherapy assistance, or were admitted to post-care facilities. At 6 months post-discharge, 91.0% of the 136 patients (n = 119) were evaluated and 36.0% had persistent malnutrition, 14.3% complained of a significant decrease in muscle strength and 14.9% had a performance status > 2. Obesity was more frequent in patients with impairment than in those without (52.8% vs. 31.0%; Obese subjects as well as patients who have stayed in intensive care have a higher risk of functional loss or undernutrition 6 months after a severe COVID infection. Malnutrition and loss of muscle strength should be considered in the clinical assessment of these patients.
Identifiants
pubmed: 34836219
pii: nu13113964
doi: 10.3390/nu13113964
pmc: PMC8618979
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Références
BMC Geriatr. 2019 Jul 3;19(1):183
pubmed: 31269909
Clin Nutr. 2015 Jun;34(3):335-40
pubmed: 25799486
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Clin Nutr. 2022 Dec;41(12):2980-2987
pubmed: 34353669
Clin Infect Dis. 2022 Apr 9;74(7):1191-1198
pubmed: 34223884
Int J Neurosci. 2023 Jul;133(7):754-769
pubmed: 34433369
J Clin Invest. 1991 Jan;87(1):262-9
pubmed: 1985100
Otolaryngol Head Neck Surg. 2020 Jul;163(1):3-11
pubmed: 32369429
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Clin Nutr ESPEN. 2021 Oct;45:351-355
pubmed: 34620339
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
J Cachexia Sarcopenia Muscle. 2021 Feb;12(1):9-13
pubmed: 33382211
BMJ Open. 2021 Jul 14;11(7):e048948
pubmed: 34261689
Eur J Clin Nutr. 2020 Jun;74(6):871-875
pubmed: 32322046
Clin Nutr. 2019 Feb;38(1):1-9
pubmed: 30181091
Clin Nutr. 2022 Dec;41(12):3069-3076
pubmed: 33934924
Clin Nutr. 2021 Jan;40(1):174-180
pubmed: 32430249
Epidemiol Infect. 2021 Jan 19;149:e32
pubmed: 33461632
Clin Nutr. 2009 Apr;28(2):134-40
pubmed: 19223093
Int J Mol Sci. 2020 Jun 30;21(13):
pubmed: 32630032
Sci Rep. 2021 Jul 22;11(1):14974
pubmed: 34294743
J Clin Neurosci. 2020 Aug;78:1-7
pubmed: 32563494
Cells. 2021 Jul 27;10(8):
pubmed: 34440669
Nutrients. 2021 Sep 21;13(9):
pubmed: 34579171
Ann Intern Med. 2020 Jun 2;172(11):726-734
pubmed: 32282894
Aging Clin Exp Res. 2021 Oct;33(10):2887-2898
pubmed: 34328636
J Gastroenterol Hepatol. 2021 Jun;36(6):1414-1422
pubmed: 33150978
Arthritis Rheum. 2007 Apr 15;57(3):429-39
pubmed: 17394228
J Neural Transm (Vienna). 2018 Jun;125(6):925-930
pubmed: 29470631
Clin Nutr ESPEN. 2021 Jun;43:174-183
pubmed: 34024511
Aging Dis. 2020 May 9;11(3):668-678
pubmed: 32489711
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Lancet Respir Med. 2021 Dec;9(12):1467-1478
pubmed: 34416191
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Pharmaceuticals (Basel). 2021 Sep 17;14(9):
pubmed: 34577633